Jim Mellon features in Barclays ‘New Advances in the Biology of Aging’.

May 10, 2019

As part of the ‘Beyond 100’ programme from November 2018, Barclays released a video discussing the science of longevity and the implications of living until 120.

Jim Mellon, chairman of Juvenescence, discusses in the video how science is elucidating the fundamental biological mechanisms of aging, and taking strides to manipulate the cellular processes leading to age-related diseases.

Mike West, CEO of our pipeline company AgeX Therapeutics, also features to discuss how stem cell therapies could be used for repairing aged tissues and treating degenerative diseases that accompany old age.

Link to the report found here.